Takeda Pharmaceutical (TAK) Stock Chart - Revenue & Earnings | Quarter Chart
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Current Ratio
Quick Ratio
Cash & Equivalents
Total Assets
Total Liabilities
Shareholders Equity
Asset Composition
Debt Structure
Takeda Pharmaceutical (TAK) quarterly earnings & revenue
Takeda Pharmaceutical (TAK) is the #431 largest public company in the world by market capitalization, operating in the Drug Manufacturers - Specialty & Generic industry.
Takeda Pharmaceutical (TAK) has a dedicated financial chart page covering quarterly revenue, earnings, cash flow, balance-sheet metrics, and valuation ratios. Sign in to check the company access available with your account.
Takeda Pharmaceutical (TAK) — frequently asked questions
What financial charts are available for Takeda Pharmaceutical (TAK)?
The Takeda Pharmaceutical chart page covers quarterly revenue, earnings, cash flow, balance-sheet metrics, and valuation ratios.
How can I view TAK's quarterly financial history?
Sign in to check your company allowance or compare Quarter Chart plans for access.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)